Sue Currie
Direttore operativo presso Virion Therapeutics LLC
Profilo
Sue Currie is currently the Chief Operating Officer at Virion Therapeutics LLC since 2021.
Previously, she worked as the Vice President & Head-Medical Affairs at Nektar Therapeutics.
Dr. Currie completed her undergraduate degree at the University of Saskatchewan, her graduate degree at the University of Phoenix, and her doctorate at the University of San Francisco.
Posizioni attive di Sue Currie
Società | Posizione | Inizio |
---|---|---|
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Direttore operativo | 22/11/2021 |
Precedenti posizioni note di Sue Currie
Società | Posizione | Fine |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Formazione di Sue Currie
University of Saskatchewan | Undergraduate Degree |
University of Phoenix | Graduate Degree |
University of San Francisco | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
Aziende private | 1 |
---|---|
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
- Borsa valori
- Insiders
- Sue Currie